CONTENTS:
- Social domains of discrimination against people who inject drugs: Links with health and wellbeing. Couto E.C.C., Salom C., Parsell C., Dietze P., Burns L., Alati R., art. 102620.
- Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence. Larney S., Leung J., Grebely J., Hickman M., Vickerman P., Peacock A., et al., art. 102656.
- An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Green T.C., Park J.N., Gilbert M., McKenzie M., Struth E., Lucas R., et al., art. 102661.
- The effect of an opioid prescription days' supply limit on patients receiving long-term opioid treatment. Yenerall J., McPheeters M., art. 102662.
- Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs. Trayner K.M.A., McAuley A., Palmateer N.E., Goldberg D.J., Shepherd S.J., Gunson R.N., et al., art. 102663.
- Known fentanyl use among clients of harm reduction sites in British Columbia, Canada. Karamouzian M., Papamihali K., Graham B., Crabtree A., Mill C., Kuo M., et al., art. 102665.
- Effects of strengthening alcohol labels on attention, message processing, and perceived effectiveness: A quasi-experimental study in Yukon, Canada. Hobin E., Schoueri-Mychasiw N., Weerasinghe A., Vallance K., Hammond D., Greenfield T.K., et al., art. 102666.
- Drugs and drug wars as populist tropes in Asia: Illustrative examples and implications for drug policy. Lasco G., art. 102668.
- The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs. Walters S.M., Coston B., Neaigus A., Rivera A.V., Starbuck L., Ramirez V., et al., art. 102671.
- Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis. Al-Banaa I., Hawkins L., Hill S.L., Lupton D.J., Jackson G., Sandilands E.A., et al., art. 102672.
- International drug control governance: Is a joint UN programme on drugs relevant? Tinasti K., art. 102687.
- Social media surveillance for perceived therapeutic effects of cannabidiol (CBD) products. Tran T., Kavuluru R., art. 102688.
- "You have to make some money before you can do some good": Balancing the commercial, social and public health objectives in a "community enterprise" regulatory model for alcohol and cannabis. Rychert M., Wilkins C., art. 102689.
- Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting. Lafferty L., Rance J., Grebely J., Dore G.J., Lloyd A.R., Treloar C., art. 102693.
- Trajectories of retention in opioid agonist therapy in a Canadian setting. Socias M.E., Dong H., Wood E., Brar R., Richardson L., Hayashi K., et al., art. 102696.
- Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study. Hammond D., Goodman S., Wadsworth E., Rynard V., Boudreau C., Hall W., art. 102698.
- Re-configured pleasures: How young people feel good through abstaining or moderating their drinking. Caluzzi G., MacLean S., Pennay A., art. 102709.
- Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds. Sznitman S.R., Pinsky-Talbi L., Salameh M., Moed T., Bentur Y., art. 102711.